|
Re: Aromatase Inhibitors/Weakly ER +
Hi Karen,
I asked two doctors and they could not give me percentages of how much AI's would benefit me. That is a bit worrisome.
Where is the research to show it works for weakly ER+?
Who has done the research - the drug companies? (Little bias there).
I agree. I finished chemo in March and am still on Herceptin. That is supposed to be the so called magic bullet for HER2 positive but now the medical world wants to add yet another drug that is still in trials?
I'm done being a guinea pig!
Diannes
__________________
Three years and 5 months NED
Dx: Aug 2008 right breast IDC with 50% of tumor DCIS, Stage II or IIA, tumor size: 2.1 cm
Grade 3
8/9 Richardson/Bloom test
ER+ weakly positive
Alred Score: 4 (suggesting I would strongly benefit from hormone therapy)
PR-,
HER2 positive +++
No vascular invasion
No lymph nodes involved
Surgery: Sept. 9, 2008 -Modified radical mastectomy, right breast. I chose to have a simple mastectomy on the left. Began Taxotere/Carboplatin/Herceptin November, 2008. Finished T/C March 2009. Finished #16 Herceptin Sept. 09. AI's and Tamoxifen made me sick. Began natural Tamoxifen which is Quercetin, I3C and a combo of other supplements. I am also a DES Daughter. There is now a link between DES exposure in utero and breast cancer!
|
Hybrid Mode
